409 results on '"Ni, Ruiqing"'
Search Results
2. Relationship Between Reactive Astrocytes, by [18F]SMBT-1 Imaging, with Amyloid-Beta, Tau, Glucose Metabolism, and TSPO in Mouse Models of Alzheimer’s Disease
3. NRF2 Deficiency Promotes Ferroptosis of Astrocytes Mediated by Oxidative Stress in Alzheimer’s Disease
4. Noninvasive Visualization of Amyloid-Beta Deposits in Alzheimer’s Amyloidosis Mice via Fluorescence Molecular Tomography Using Contrast Agent
5. Evaluation of novel anti-CEACAM6 antibody-based conjugates for radioimmunotheranostics of pancreatic ductal adenocarcinoma
6. Myricetin ameliorates cognitive impairment in 3×Tg Alzheimer’s disease mice by regulating oxidative stress and tau hyperphosphorylation
7. Gastrodin ameliorates synaptic impairment, mitochondrial dysfunction and oxidative stress in N2a/APP cells
8. In vivo reactive astrocyte imaging using [18F]SMBT-1 in tauopathy and familial Alzheimer's disease mouse models: A multi-tracer study
9. Deep learning facilitates fully automated brain image registration of optoacoustic tomography and magnetic resonance imaging
10. Noninvasive three-dimensional optoacoustic localization microangiography of deep tissues
11. Imaging increased metabolism in the spinal cord in mice after middle cerebral artery occlusion
12. In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRI
13. Collection on molecular imaging in neurodegeneration
14. Aquaporin 4 is differentially increased and dislocated in association with tau and amyloid-beta
15. Multiscale optical and optoacoustic imaging of amyloid-β deposits in mice
16. Hippocampal mGluR5 levels are comparable in Alzheimer′s and control brains, and divergently influenced by amyloid and tau in control brain
17. Increased Cerebral Level of P2X7R in a Tauopathy Mouse Model by PET Using [18F]GSK1482160
18. Non-invasive imaging of tau-targeted probe uptake by whole brain multi-spectral optoacoustic tomography
19. Hybrid magnetic resonance and optoacoustic tomography (MROT) for preclinical neuroimaging
20. Effect of APOE ɛ4 Status on Brain Amyloid‐β and Cognitive Function in Amnestic and Nonamnestic Mild Cognitive Impairment: A [18F] Florbetapir PET‐CT Study.
21. Multi-scale optoacoustic molecular imaging of brain diseases
22. Reduced SV2A and GABAA receptor levels in the brains of type 2 diabetic rats revealed by [18F]SDM-8 and [18F]flumazenil PET
23. Hippocampal purinergic P2X7 receptor level is increased in Alzheimer’s disease patients, and associated with amyloid and tau pathologies
24. Advances in non-invasive imaging of proteinopathies in animal models of neurodegenerative diseases
25. In-vitro and in-vivo characterization of CRANAD-2 for multi-spectral optoacoustic tomography and fluorescence imaging of amyloid-beta deposits in Alzheimer mice
26. Increased Cerebral Level of P2X7R in a Tauopathy Mouse Model by PET Using [18F]GSK1482160.
27. Presynaptic density determined by SV2A PET is closely associated with postsynaptic metabotropic glutamate receptor 5 availability and independent of amyloid pathology in early cognitive impairment.
28. In vivo [18F]SMBT‐1 imaging of reactive astrocytes in mouse models of Alzheimer’s disease ‐ temporospatial relationship with amyloid, tau and microgliosis
29. MRI reveals cerebral iron, calcification and spinal cord atrophy in M83 mouse model of Parkinson’s disease
30. Automatic analysis of skull thickness, scalp‐to‐cortex distance and association with age and sex in cognitively normal elderly
31. SWI and phase imaging reveal intracranial calcifications in the P301L mouse model of human tauopathy
32. Probing Chemical Complexity of Amyloid Plaques in Alzheimer's Disease Mice using Hyperspectral Raman Imaging.
33. Reduced SV2A and GABAAreceptor levels in the brains of type 2 diabetic rats revealed by [18F]SDM-8 and [18F]flumazenil PET
34. NRF2 deficiency promotes ferroptosis of astrocytes mediated by oxidative stress in Alzheimer’s disease
35. Relationship between reactive astrocytes, by [18F]SMBT-1 imaging, with amyloid-beta, tau, glucose metabolism, and microgliosis in mouse models of Alzheimer′s disease
36. Inorganic phosphate exporter heterozygosity in mice leads to brain vascular calcification, microangiopathy, and microgliosis
37. Cortical hypoperfusion and reduced cerebral metabolic rate of oxygen in the arcAβ mouse model of Alzheimer’s disease
38. Positron emission tomography of type 2 cannabinoid receptors for detecting inflammation in the central nervous system
39. Coregistered transcranial optoacoustic and magnetic resonance angiography of the human brain
40. Automatic analysis of skull thickness, scalp-to-cortex distance and association with age and sex in cognitively normal elderly
41. Visualizing alpha-synuclein and iron deposition in M83 mouse model of Parkinson’s diseasein vivo
42. Deep optoacoustic localization microangiography of ischemic stroke in mice
43. Aquaporin 4 is associated with cerebral amyloid‐beta and tau deposits in mouse models
44. Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease
45. Efficient characterization of multiple binding sites of small molecule imaging ligands on amyloid-beta, 4-repeat/full-length tau and alpha-synuclein
46. Monitoring mouse brain perfusion with hybrid magnetic resonance optoacoustic tomography
47. PET imaging in animal models of Parkinson’s disease
48. Coregistered transcranial optoacoustic and magnetic resonance angiography of the human brain
49. Gastrodin ameliorates synaptic impairment, reestablishes mitochondrial membrane potential and reduces oxidative stress in N2a/APP cells through ERK1/2 and GSK-3β pathways
50. Myricetin protected against Aβ oligomer-induced synaptic impairment, mitochondrial function and oxidative stress in SH-SY5Y cells via ERK1/2/GSK-3β pathways
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.